Average Co-Inventor Count = 11.00
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (39 from 3,221 patents)
2. Array Biopharma Inc. (14 from 329 patents)
3. Constellation Pharmaceuticals, Inc. (5 from 54 patents)
4. Merck + Co., Inc. (2 from 4,770 patents)
5. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
6. F. Hoffmann-la Roche Ag (2 from 168 patents)
7. Genetech, Inc. (1 from 98 patents)
8. Covenentech, Inc. (1 from 1 patent)
9. Genertech, Inc. (1 from 1 patent)
10. Hoffman-laroche, Inc. (us Only) (1 from 1 patent)
11. F. Hoffman-laroche, Ag (ex-us) (1 from 1 patent)
48 patents:
1. 12473301 - Isoquinoline compounds for the treatment of cancer
2. 12378249 - Isoquinoline compounds and uses thereof
3. 12297210 - Naphthyridine compounds and uses thereof
4. 12233052 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
5. 12187709 - Lactams as CBL-B inhibitors selective over C-CBL
6. 11612606 - 8-aminoisoquinoline compounds and uses thereof
7. 11566003 - Isoquinolines as inhibitors of HPK1
8. 11034692 - Naphthyridines as inhibitors of HPK1
9. 11034698 - Pyrazolo[ 1,5a]pyrimidine derivatives as IRAK4 modulators
10. 10988478 - Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
11. 10966963 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
12. 10899772 - IRAK4 modulators
13. 10654867 - Heteroaryl estrogen receptor modulators and uses thereof
14. 10407424 - Naphthyridines as inhibitors of HPK1
15. 10399939 - Tetrahydronaphthalene estrogen receptor modulators and uses thereof